ArticleAnnals of medicine2023

The anti-tumor efficiency of low-dose apatinib-based chemotherapy in pretreated HER2-negative breast cancer with brain metastases.

Xuelian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.